|
1
|
- Draft Description
- October 6, 2004
|
|
2
|
- Focused on improving outpatient medication safety, esp. re: high-risk
drugs
- Emphasis on consumer perspective
- More than 65 organizations are members or active participants
- Staffed and coordinated by National Consumers League
- www.sosrx.org
|
|
3
|
- Warfarin campaign. Imp=
roving
patient safety and reducing risk of dangerous interactions
- E-prescribing. Helping
consumers understand benefits and promote adoption
- Personal medication record.
Developing template and encouraging use of PMR
- Clearinghouse of safe practices
|
|
4
|
- High risk of harm with outpatient drug use
- From 1990-2002, Rx drug use by seniors increased by XX%
- In same period, number of adverse drug events (ADEs) increased from =
X to
Y
- Cost per ADE estimated at $12,000
- 40% of those 65+ take 5 or more drugs
|
|
5
|
- Many public and private efforts to improve this dismal record, BUT=
li>
- To date, little careful study, few controlled trials to determine wh=
at
works for outpatients
|
|
6
|
- Example: Warfarin
- Clinicians need access to evidence-based best practices re: warfarin=
AND
- Info on how best to communicate with patients on warfarin
- Consumers need to know what Q’s to ask and what actions to tak=
e
- Insurers, employers, others need to know how to educate warfarin use=
rs
|
|
7
|
- Clearinghouse also a useful tool to translate research on patient
compliance into better, safer clinical practice
|
|
8
|
- Clearinghouse will fill gaps in existing databases
- Cochrane Collaboration compiles data on X
- National Library of Medicine on Y
- Institute for Safe Medical Practices on Z
- AHRQ clearinghouses on A
- NQF does B
|
|
9
|
- SOS Rx Clearinghouse will:
- Collect evidence and literature about safest practices re: high-risk
drugs in outpatient setting
- Assemble, catalogue, and maintain online database
- Include public and private sector research reports, plus generalized
information from other settings, etc.
- Make all accessible to clinicians and consumers
|
|
10
|
- Clearinghouse working group of experts met March 2004 and produced
consensus document on scope, governance and related issues
- Currently seeking partner organization with capacity to help develop=
and
house clearinghouse
- Seeking funds and in-kind resources
|
|
11
|
- Lou Diamond, Medstat, coordinates working group. Staff support from National Consumers League=
li>
- Start-up SOS Rx grant from Express Scripts
- Timeline?
- Other questions?
|
|
12
|
- Have three phases:
- 1) Prototype
- 2) Pilot
- 3) Fully operational clearinghouse
|
|
13
|
- Develop prototype, a mock-up focused on only one high-risk drug
(probably warfarin)
- AHRQ Safe Practices Report a possible model
- Budget for Prototype: $10,000 (in hand)
|
|
14
|
- Use Prototype to pitch project to potential partners, funders, hosts=
- Develop pilot – live, online version of clearinghouse with
structured evaluation of users
- Budget for pilot: $100,000 (needed)
|
|
15
|
- Once funding is secured, develop and test pilot
- Continue seeking host and resources for full-scale effort
|